Eaton Vance Worldwide Health Sciences Fund Class I (EIHSX)
Fund Assets | 1.02B |
Expense Ratio | 0.92% |
Min. Investment | $250,000 |
Turnover | n/a |
Dividend (ttm) | 0.66 |
Dividend Yield | 4.85% |
Dividend Growth | 84.44% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 5, 2024 |
Previous Close | 13.32 |
YTD Return | 1.42% |
1-Year Return | 1.10% |
5-Year Return | 44.45% |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 49 |
Inception Date | Oct 1, 2009 |
About EIHSX
The Fund's investment strategy focuses on GL Health/Biotech with 0.97% total expense ratio. The minimum amount to invest in Eaton Vance Growth Trust: Eaton Vance Worldwide Health Sciences Fund; Class I Shares is $250,000 on a standard taxable account. Eaton Vance Growth Trust: Eaton Vance Worldwide Health Sciences Fund; Class I Shares seeks long-term capital growth by investing in a global, diversified portfolio of securities of health science companies. EIHSX normally invests at least 80% of its assets in securities of companies primarily engaged in the discovery, development, production or distribution of products related to health care.
Performance
EIHSX had a total return of 1.10% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.57%.
Top 10 Holdings
51.39% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 11.14% |
AbbVie Inc. | ABBV | 6.36% |
Novo Nordisk A/S | NOVO.B | 5.24% |
AstraZeneca PLC | AZN | 4.92% |
Abbott Laboratories | ABT | 4.53% |
UnitedHealth Group Incorporated | UNH | 4.21% |
Roche Holding AG | ROG | 4.20% |
Bristol-Myers Squibb Company | BMY | 3.66% |
Thermo Fisher Scientific Inc. | TMO | 3.58% |
Intuitive Surgical, Inc. | ISRG | 3.56% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 5, 2024 | $0.6601 | Dec 6, 2024 |
Dec 7, 2023 | $0.3579 | Dec 8, 2023 |
Dec 8, 2022 | $0.5963 | Dec 9, 2022 |
Dec 9, 2021 | $1.2418 | Dec 10, 2021 |
Dec 10, 2020 | $0.988 | Dec 11, 2020 |
Dec 3, 2019 | $0.6966 | Dec 4, 2019 |